Skip to main content
Equibles

UBS Group AG

Position in LNSR — LENSAR, Inc.

CIK 1610520 ZURICH, V8
Back to LNSR Full portfolio

Position in LNSR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$488,969
-$7,331 QoQ
Shares Held
85,634
+2.8% QoQ
Ownership
0.697%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 74 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 16% Shared 0% None 84%

Common Shares in LNSR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS Group AG holds $4,686,473,125 across 138 Medical Devices names. LNSR ranks #77 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 16,352,420 $697,921,281
2 ABT
Abbott Laboratories
 7,356,093 $667,491,874
3 SYK
Stryker Corp
 1,909,680 $601,243,647
4 MDT
Medtronic plc
 5,551,443 $434,289,383
5 DXCM
Dexcom Inc
 6,065,779 $408,530,211
6 ZBH
Zimmer Biomet Holdings, Inc.
 2,758,615 $237,489,163
7 PEN
Penumbra Inc
 703,822 $222,231,795
8 EW
Edwards Lifesciences Corp
 2,350,656 $212,640,338

All Filings in LNSR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $488,969 85,634
2026-03-31 $496,300 83,272
2025-12-31 $97,540 8,387
2025-09-30 $93,723 7,589
2025-06-30 $193,980 14,729
2025-03-31 $177,007 12,536
2024-12-31 $4,836 541
2024-09-30 $2,537 554
2024-06-30 $2,493 554
2024-03-31 $11,470 3,377
2023-12-31 $3,337 951
2023-09-30 $1,578 511
2023-06-30 $786 185
2023-03-31 $460 185
2022-12-31 $547 185
2022-09-30 $3,119 562
2022-06-30 $5,370 825
2022-03-31 $5,024 679
2021-12-31 $22,221 3,710
2021-09-30 $28,717 3,754
2021-06-30 $33,851 3,909
2021-03-31 $68,460 9,430
2020-12-31 $54,795 7,558